Page last updated: 2024-09-03

gefitinib and Ewing Sarcoma

gefitinib has been researched along with Ewing Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berglund, C; Chernoguz, A; Crawford, K; Cripe, TP; Donovan, E; Frischer, JS; Vandersall, A	1

Other Studies

1 other study(ies) available for gefitinib and Ewing Sarcoma

Article	Year
EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model. The Journal of surgical research, 2012, Volume: 173, Issue:1 Topics: Angiography; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; ErbB Receptors; Female; Gefitinib; Humans; In Vitro Techniques; Mice; Mice, Nude; Neovascularization, Pathologic; Quinazolines; Sarcoma, Ewing; Transplantation, Heterologous; Vascular Endothelial Growth Factor A	2012

Article

Year

EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.

The Journal of surgical research, 2012, Volume: 173, Issue:1

Topics: Angiography; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; ErbB Receptors; Female; Gefitinib; Humans; In Vitro Techniques; Mice; Mice, Nude; Neovascularization, Pathologic; Quinazolines; Sarcoma, Ewing; Transplantation, Heterologous; Vascular Endothelial Growth Factor A

2012